About Cidmus

Cidmus is a Healthcare company, and was acquired by Dr. Reddy's Laboratories in April 2022. Manufacturer of drugs. Its focus areas include Traditional Pharmaceuticals.

Company details

Cidmus manufacturer of drugs, focusing on providing healthcare solutions, and traditional pharmaceuticals. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics

Investors in Cidmus

Cidmus has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Dr. Reddy's Laboratories.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Innovative medicines are developed and manufactured globally by the company.
1984drreddys.comHyderabad, India
Premium access

Investor details for Cidmus

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Cidmus

Cidmus manufacturer of drugs, focusing on providing healthcare solutions, and traditional pharmaceuticals. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.

Cidmus has 1 investor. Key investors include Dr. Reddy's Laboratories.

Yes. Cidmus was acquired by Dr. Reddy's Laboratories in April 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available